7.200EUR0.00%Mkt Cap: 33.86M $P/E: Infinity2d ago
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic a…
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.47BUSDP/E 179.2
$14.18BUSDP/E 29.7
$12.96BUSD
$8.93BUSDP/E 22.7
$7.80BUSD
$6.84BUSDP/E 25.1
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.65BUSDP/E 19.0
$3.55BUSDP/E 11.3
$2.99BUSDP/E 20.9
$2.80BUSD
$2.52BUSDP/E 56.0
$2.35BUSDP/E 16.3
$2.40BUSDP/E 12.9
$2.31BUSD
$1.92BUSDP/E 19.4
$1.89BUSD
$1.86BUSDP/E 21.0
$1.71BUSD
$1.89BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.12BUSDP/E 35.4
$1.18BUSDP/E 17.6
$1.23BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$918.60MUSDP/E 14.7
$873.22MUSDP/E 38.1
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$668.29MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$505.77MUSDP/E 14.3
$494.34MUSD
$447.41MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$357.30MUSD
$320.48MUSDP/E 43.7
$294.94MUSDP/E 15.2
$303.08MUSDP/E 9.7
$273.62MUSDP/E 49.1
$285.23MUSD
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$236.39MUSDP/E 53.0
$206.95MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.26MUSDP/E 18.3
$146.07MUSD
$133.59MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$83.73MUSDP/E 12.0
$94.75MUSD
$72.66MUSD
$67.25MUSD
$70.06MUSD
$62.42MUSDP/E 52.6
$63.44MUSDP/E 21.8
$60.48MUSD
$63.41MUSD
$53.86MUSD
$50.62MUSD
$49.37MUSD
$48.31MUSD
$42.20MUSD
$41.16MUSD
$31.75MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.56MUSD
$17.65MUSD
$14.93MUSD
$13.84MUSDP/E 16.8
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.05MUSDP/E 3.7
$6.17MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$2.01MUSD
$1.93MUSD
$2.08MUSDP/E 35.5
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap33.86M $
Enterprise Value19.91M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)0 $
Revenue/Share—
Last Price7.200 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2
CountryIE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)Infinity
P/E (Forward)-60.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.81
EPS (TTM)0.00
EPS (Forward)-0.12
52W Range
7.0009% of range9.300
52W High9.300 EUR
52W Low7.000 EUR
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE0.00%
ROA0.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.41M $
CapEx (TTM)—
FCF Margin—
FCF Yield-2.93%
Net Debt-14.02M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio16.13
Quick Ratio16.13
Book Value/Sh8.904 EUR
Cash/Share2.976 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)15.50 EUR
Upside (mean)+115.3%
Target Range15.50 EUR – 15.50 EUR
# Analysts1
Ownership
Shares Out.4.33M
Float892.64K
Insiders34.96%
Institutions44.29%
Technical
SMA 507.495 (-3.9%)
SMA 2007.819 (-7.9%)
Beta0.43
S&P 52W Chg20.25%
Avg Vol (30d)191
Avg Vol (10d)9
Technical Indicators
RSI (14)32.8
MACD-0.1017
MACD Signal-0.1055
MACD Hist.+0.0037
BB Upper7.495 EUR
BB Middle7.300 EUR
BB Lower7.105 EUR
BB Width5.33%
ATR (14)0.0394 EUR
Vol Ratio (20d)0.00x